Loading viewer...
investor_presentation
Format: PDF investor_presentation
Rieter's October 2023 investor update detailing third-quarter performance with CHF 334.7 million in sales and CHF 127.2 million in order intake. The presentation outlines the "Next Level" performance program focused on sales excellence, competitive products, and agile structures while confirming full-year 2023 outlook.
investor_presentation
85 Pages
Rocket Pharmaceuticals
Pilgrim's Pride Investor Presentation — September 2017
investor_presentationinvestor_presentation
158 Pages
Pilgrim’s Pride Corporation